Replies to post #196745 on Biotech Values

[Bickema]

I'm looking over EGRX now. And they appear to have a bright future with a nice cash position. Management seemed super optimistic on the last ER CC.

Whats kinda strange is they are partnered with Teva for Bendamustine II but at the same time competing with them Bendamustine (RTD) 500mL?

On the last CC the CEO had nothing but the utmost praise and respect for TEVA. Seems like the two should just tie the knot.

[Bickema]

EGRX +31% since your post. nicely done.